TECH · Categories · Form 4
TECH - SEC Form 4 insider transactions
Bio-Techne Corp (TECH) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for TECH
- SEC Form 4 filed by SVP - General Counsel Bohnen Shane4 - BIO-TECHNE Corp (0000842023) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Kelderman Kim4 - BIO-TECHNE Corp (0000842023) (Issuer)
- SEC Form 4 filed by CFO Hippel James4 - BIO-TECHNE Corp (0000842023) (Issuer)
- SEC Form 4 filed by President - Diag & Spatial Bi Crouse Steven C.4 - BIO-TECHNE Corp (0000842023) (Issuer)
- SEC Form 4 filed by PRESIDENT, PROTEIN SCIENCES Geist William4 - BIO-TECHNE Corp (0000842023) (Issuer)
- SEC Form 4 filed by Director Herr Amy E.4 - BIO-TECHNE Corp (0000842023) (Issuer)
- Chief Executive Officer Kelderman Kim converted options into 21,470 shares and covered exercise/tax liability with 10,821 shares, increasing direct ownership by 15% to 82,762 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- PRESIDENT, PROTEIN SCIENCES Geist William covered exercise/tax liability with 1,976 shares and converted options into 6,416 shares, increasing direct ownership by 22% to 24,943 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- CFO Hippel James covered exercise/tax liability with 4,310 shares and converted options into 9,779 shares, increasing direct ownership by 3% to 170,183 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- SVP - General Counsel Bohnen Shane converted options into 4,350 shares and covered exercise/tax liability with 1,343 shares, increasing direct ownership by 41% to 10,360 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- Director Herr Amy E. converted options into 589 shares and covered exercise/tax liability with 213 shares (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- President - Diag & Spatial Bi Crouse Steven C. converted options into 5,423 shares and covered exercise/tax liability with 1,947 shares, increasing direct ownership by 51% to 10,237 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- CFO Hippel James exercised 62,068 shares at a strike of $47.60 and covered exercise/tax liability with 51,024 shares, increasing direct ownership by 7% to 164,714 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- Chief Executive Officer Kelderman Kim exercised 35,000 shares at a strike of $47.60 and covered exercise/tax liability with 28,686 shares, increasing direct ownership by 10% to 72,113 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- SVP - General Counsel Bohnen Shane exercised 448 shares at a strike of $47.60 and covered exercise/tax liability with 344 shares, increasing direct ownership by 1% to 7,353 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- President - Diag & Spatial Bi Crouse Steven C. converted options into 600 shares and covered exercise/tax liability with 216 shares, increasing direct ownership by 6% to 6,761 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- Director Herr Amy E. sold $320,386 worth of shares (6,636 units at $48.28) and exercised 6,636 shares at a strike of $47.60 (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- CFO Hippel James covered exercise/tax liability with 56,955 shares and exercised 62,000 shares at a strike of $47.60, increasing direct ownership by 3% to 153,670 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- SVP - General Counsel Bohnen Shane exercised 8,400 shares at a strike of $47.60 and covered exercise/tax liability with 7,055 shares, increasing direct ownership by 23% to 7,249 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- Chief Executive Officer Kelderman Kim exercised 26,692 shares at a strike of $47.60 and covered exercise/tax liability with 23,951 shares, increasing direct ownership by 4% to 65,799 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- President - Diag & Spatial Bi Crouse Steven C. converted options into 794 shares and covered exercise/tax liability with 311 shares, increasing direct ownership by 8% to 6,337 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- Chief Executive Officer Kelderman Kim converted options into 11,344 shares and covered exercise/tax liability with 1,363 shares, increasing direct ownership by 19% to 63,058 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- CFO Hippel James covered exercise/tax liability with 56,097 shares and converted options into 62,000 shares, increasing direct ownership by 4% to 148,625 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- SEC Form 4 filed by Kelderman Kim4 - BIO-TECHNE Corp (0000842023) (Issuer)
- SEC Form 4 filed by Bohnen Shane4 - BIO-TECHNE Corp (0000842023) (Issuer)
- SEC Form 4 filed by President - Diag & Spatial Bi Crouse Steven C.4 - BIO-TECHNE Corp (0000842023) (Issuer)
- Director Herr Amy E. sold $116,791 worth of shares (1,976 units at $59.10) (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- Director Herr Amy E. covered exercise/tax liability with 16 shares and converted options into 38 shares (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- President - Diag & Spatial Bio Mcmanus Matthew converted options into 4,621 shares and covered exercise/tax liability with 1,665 shares, increasing direct ownership by 62% to 7,691 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- Chief Executive Officer Kelderman Kim covered exercise/tax liability with 2,303 shares, decreasing direct ownership by 5% to 48,665 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- CFO Hippel James converted options into 24,704 shares and covered exercise/tax liability with 11,865 shares, increasing direct ownership by 10% to 142,722 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- PRESIDENT, PROTEIN SCIENCES Geist William converted options into 9,911 shares and covered exercise/tax liability with 4,520 shares, increasing direct ownership by 36% to 20,503 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- Director Bushman Julie L was granted 1,640 shares, increasing direct ownership by 23% to 8,775 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- Director Keegan Joseph D was granted 1,640 shares, increasing direct ownership by 12% to 15,411 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- Director Higgins John L was granted 1,640 shares, increasing direct ownership by 3% to 66,876 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- Director Seth Alpna was granted 1,640 shares, increasing direct ownership by 12% to 15,411 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- Director Herr Amy E. was granted 1,640 shares, increasing direct ownership by 158% to 2,680 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- Director Klimovsky Judith V. was granted 1,640 shares, increasing direct ownership by 77% to 3,782 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- Director Vessey Rupert was granted 1,640 shares, increasing direct ownership by 18% to 10,987 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- Director Baumgartner Robert V was granted 1,640 shares, increasing direct ownership by 4% to 46,503 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- Director Nusse Roeland exercised 17,040 shares at a strike of $21.84 and sold $960,388 worth of shares (17,040 units at $56.36) (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- Director Baumgartner Robert V exercised 17,040 shares at a strike of $21.84 and sold $957,818 worth of shares (17,040 units at $56.21) (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- CFO Hippel James converted options into 4,010 shares and covered exercise/tax liability with 1,926 shares, increasing direct ownership by 2% to 129,883 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- Director Herr Amy E. converted options into 279 shares and covered exercise/tax liability with 101 shares (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- Chief Executive Officer Kelderman Kim converted options into 8,543 shares and covered exercise/tax liability with 4,305 shares, increasing direct ownership by 9% to 50,968 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- SVP - General Counsel Bohnen Shane converted options into 1,718 shares and covered exercise/tax liability with 527 shares, increasing direct ownership by 37% to 4,385 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- President - Diag & Spatial Bio Mcmanus Matthew converted options into 2,637 shares and covered exercise/tax liability with 880 shares, increasing direct ownership by 59% to 4,735 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- PRESIDENT, PROTEIN SCIENCES Geist William converted options into 2,623 shares and covered exercise/tax liability with 803 shares, increasing direct ownership by 14% to 15,112 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- Director Higgins John L exercised 5,040 shares at a strike of $21.84, increasing direct ownership by 8% to 65,236 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- CFO Hippel James covered exercise/tax liability with 147,431 shares and exercised 168,620 shares at a strike of $44.33, increasing direct ownership by 20% to 127,799 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- Chief Executive Officer Kelderman Kim covered exercise/tax liability with 43,649 shares and exercised 48,176 shares at a strike of $44.33, increasing direct ownership by 11% to 46,730 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- Chief Executive Officer Kelderman Kim exercised 36,132 shares at a strike of $44.33 and covered exercise/tax liability with 32,933 shares, increasing direct ownership by 8% to 42,203 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- Director Herr Amy E. exercised 1,280 shares at a strike of $44.33 and sold $63,705 worth of shares (1,280 units at $49.77) (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- Director Higgins John L exercised 12,000 shares at a strike of $21.84, increasing direct ownership by 25% to 60,196 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- SVP - General Counsel Bohnen Shane converted options into 2,260 shares and covered exercise/tax liability with 747 shares, increasing direct ownership by 90% to 3,194 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- Director Herr Amy E. exercised 1,976 shares at a strike of $44.33 and sold $122,691 worth of shares (1,860 units at $65.96) (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- Director Herr Amy E. was granted 1,040 shares (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- President - DGS Mcmanus Matthew converted options into 4,620 shares and covered exercise/tax liability with 1,642 shares (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- PRESIDENT, PROTEIN SCIENCES Geist William converted options into 3,320 shares and covered exercise/tax liability with 1,109 shares, increasing direct ownership by 20% to 13,292 units (SEC Form 4)4 - BIO-TECHNE Corp (0000842023) (Issuer)
- Amendment: SEC Form 4 filed by President - DGS Mcmanus Matthew4/A - BIO-TECHNE Corp (0000842023) (Issuer)